Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|December 14, 2011
A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivoYonghyo Kim, Hye Jin Jung, Ho Jeong KwonCurrent Issues in Molecular Biology|December 22, 2022
API-2-Induced Cell Migration Is Overcome by Small Molecular Approaches Inhibiting β-CateninYonghyo Kim, Myoung-Hee Kang, Yong-Hee ChoMolecules and Cells|January 6, 2015
Antiangiogenic activity of the lipophilic antimicrobial peptides from an endophytic bacterial strain isolated from red pepper leafHye Jin Jung, Yonghyo Kim, Hyang Burm Lee, et al.Anti-Cancer Drugs|November 3, 2025
Collagen I is the effective therapeutic target for treating desmoid tumorsYehyeong Lee, Yonghyo Kim, Chankyoung Lee, et al.Journal of Medicinal Chemistry|September 23, 2014
Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leadsHye Jin Jung, Misun Cho, Yonghyo Kim, et al.Journal of Microbiology and Biotechnology|November 9, 2023
The Significance of N6-Methyladenosine RNA Methylation in Regulating the Hepatitis B Virus Life CycleJae-Su Moon, Wooseong Lee, Yong-Hee Cho, et al.Archives of Pharmacal Research|July 22, 2015
Antiangiogenic activity of herboxidiene via downregulation of vascular endothelial growth factor receptor-2 and hypoxia-inducible factor-1αHye Jin Jung, Yonghyo Kim, Ju Yong Shin, et al.Journal of Medicinal Chemistry|November 3, 2021
Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic ImpactSung Min Cho, Yonghyo Kim, Yooju Jung, et al.Journal of Molecular Medicine (Berlin, Germany)|May 28, 2013
Mitochondrial UQCRB regulates VEGFR2 signaling in endothelial cellsHye Jin Jung, Yonghyo Kim, Junghwa Chang, et al.Anticancer Research|December 3, 2024
Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid TumorsYehyeong Lee, Yonghyo Kim, Hyeran Shin, et al.Pageof 3